Drugs / BCG
last change Aug 2020 re-read 3 minutes ago

BCG

Vaccine

Developed for
latent tuberculosis infection
Investigated by
Federal University of Mato Grosso · Oswaldo Cruz Foundation · Stanford University

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05541952 Aug 2020 latent tuberculosis infection Federal University of Mato Grosso Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT05541952 ↗
Modality Vaccine “BCG vaccine” NCT05541952 ↗